David C Hill

Title: David C. Hill: Innovator in Glycoprotein Hormone Research

Introduction

David C. Hill is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of glycoprotein hormone polypeptides. With a total of 2 patents, his work has the potential to impact medical treatments and diagnostics.

Latest Patents

David C. Hill's latest patents include groundbreaking inventions related to nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and their heterodimers. These patents disclose novel β10 polypeptides and heterodimers, along with methods for producing these polypeptides and their respective binding agents. The inventions also provide vectors, host cells, and methods for the treatment, diagnosis, amelioration, or prevention of diseases using β10 polypeptides and α2/β10 heterodimers.

Career Highlights

David C. Hill is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative research that bridges the gap between molecular biology and therapeutic applications. His contributions have been instrumental in advancing the understanding of glycoprotein hormones.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Christopher J. R. Paszty and Jin Cao. These collaborations have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

David C. Hill's innovative work in glycoprotein hormone research exemplifies the impact of biotechnology on modern medicine. His patents and collaborations continue to pave the way for new therapeutic approaches and diagnostic tools.